1. Barbeau, A. Contribution of levodopa therapy to the neuropharmacology of akinesia. In: Parkinson’s Disease, J. Siegfried (Ed.) Hans Huber (Publ.), Bern, 151–174, 1976.
2. Inagaki, C., Fujiwara, H., Tanaka, C. Inhibitory effect of (+)threo-3,4-dihydroxyphenylserine (DOPS) on decarboxylation of (-)threo-DOPS. Jap. J. Pharmacol. 26: 380–382, 1976.
3. Martin, J.P. The basal ganglia and posture, Pitman Medical Publ. Co., London, p. 17, 1967.
4. Nagatsu, T., Kato, T., Numata, Y., Ikuta, K., Sako, M., Nagatsu, I., Kondo, Y., Inagaki, S., Iizuka, R., Hori, A., Narabayashi, H. Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin. Chim. Acta 57: 221–232, 1977.
5. Nagatsu, T., Kato, T., Nagatsu, I., Kondo, Y., Inagaki, S., Jizuka, R., Narabayashi, H. Catecholamine-related enzymes in the brain of patients with Parkinsonism and Wilson’s disease. In: Advances in Neurology, L.J. Poirier, T.L. Sourkes and P.J. Bedard (Eds.) Raven Press,New York, Vol. 24: 283–292, 1979.